These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 16895006

  • 1. Drug induced osteonecrosis of the jaws.
    Weeda LW.
    J Tenn Dent Assoc; 2006; 86(2):18-9. PubMed ID: 16895006
    [No Abstract] [Full Text] [Related]

  • 2. Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis.
    Dello Russo NM, Jeffcoat MK, Marx RE, Fugazzotto P.
    Int J Oral Maxillofac Implants; 2007; 22(1):146-53. PubMed ID: 17340909
    [No Abstract] [Full Text] [Related]

  • 3. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
    Ruggiero SL, Fantasia J, Carlson E.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
    [No Abstract] [Full Text] [Related]

  • 4. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.
    Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial SurgeonsAAOMS, Rosemont, IL 60018, USA..
    J Oral Maxillofac Surg; 2007 Mar; 65(3):369-76. PubMed ID: 17307580
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V, American Association of Oral and Maxillofacial Surgeons, American Dental Association.
    Hawaii Dent J; 2008 Mar; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bisphosphonates and bisphosphonate induced osteonecrosis.
    Sawatari Y, Marx RE.
    Oral Maxillofac Surg Clin North Am; 2007 Nov; 19(4):487-98, v-vi. PubMed ID: 18088900
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
    Fusco V, Baraldi A, Loidoris A, Ciuffreda L, Galassi C, Goia F, Scoletta M, Berrone S, Benech A, Ortega C, Berruti A, Rete Oncologia di Piemonte e Valle d'Aosta ONJ Study Group.
    J Oral Maxillofac Surg; 2009 Aug; 67(8):1775. PubMed ID: 19615599
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Management of bisphosphonate-induced osteonecrosis of the jaw.
    Schilling J.
    Northwest Dent; 2008 Aug; 87(3):34-5, 37-8, 40. PubMed ID: 18663869
    [Abstract] [Full Text] [Related]

  • 17. Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series.
    Ferlito S, Liardo C, Puzzo S.
    Minerva Stomatol; 2010 Aug; 59(11-12):593-601. PubMed ID: 21217623
    [Abstract] [Full Text] [Related]

  • 18. Treating osteonecrosis.
    Harrison Z.
    Br Dent J; 2006 Mar 11; 200(5):242-3. PubMed ID: 16528300
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.